sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation

Mol Biol Rep. 2021 Feb;48(2):1601-1606. doi: 10.1007/s11033-021-06150-1. Epub 2021 Jan 23.

Abstract

Genotyping of ST2 and galectin-3 in atrial fibrillation (AF) is not well analyzed. The aim of our study was to analyze the possible relationship between levels of sST2 and galectin-3 and three polymorphisms in patients with AF. We included 125 patients with persistent AF undergoing electric cardioversion. We analyzed sST2 and galectin-3 levels and three polymorphisms in peripheral blood samples. Rs2274273 was significantly related with levels of galectin-3. Rs1558648 was associated with levels of sST2 but rs13019803 were not. None of the polymorphisms were connected to the variation of biomarkers levels during the follow up. We found a relationship between rs2274273 and galectin-3 levels and rs1558648 and sST2 levels in patients with AF.

Keywords: Atrial fibrillation; Biomarkers; Galectin 3; Polymorphisms; sST2.

MeSH terms

  • Aged
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / genetics*
  • Atrial Fibrillation / pathology
  • Atrial Fibrillation / therapy
  • Biomarkers / blood
  • Blood Proteins / genetics*
  • Electric Countershock / adverse effects
  • Female
  • Galectins / blood
  • Galectins / genetics*
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics

Substances

  • Biomarkers
  • Blood Proteins
  • Galectins
  • Interleukin-1 Receptor-Like 1 Protein
  • LGALS3 protein, human